Stay updated with breaking news from 80067710. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sangamo Therapeutics (NASDAQ:SGMO – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a research note issued on Monday, Benzinga reports. They presently have a $5.00 price target on the biopharmaceutical company’s stock. HC Wainwright’s price target would indicate a potential upside of 405.51% from the company’s previous […]
Sangamo Therapeutics (NASDAQ:SGMO – Free Report) had its price objective lowered by Barclays from $11.00 to $9.00 in a research note issued to investors on Wednesday morning, Marketbeat Ratings reports. Barclays currently has an overweight rating on the biopharmaceutical company’s stock. SGMO has been the subject of a number of other reports. Stifel Nicolaus lowered […]
Sangamo Therapeutics (NASDAQ:SGMO – Free Report) had its target price cut by Wells Fargo & Company from $5.00 to $4.00 in a research note published on Thursday morning, Benzinga reports. They currently have an overweight rating on the biopharmaceutical company’s stock. A number of other research firms also recently issued reports on SGMO. Barclays cut […]
Sangamo Therapeutics (NASDAQ:SGMO – Free Report) was downgraded by investment analysts at StockNews.com from a “hold” rating to a “sell” rating in a report released on Tuesday. Other analysts have also recently issued research reports about the stock. Truist Financial lowered their target price on shares of Sangamo Therapeutics from $16.00 to $8.00 in a […]
StockNews.com upgraded shares of Sangamo Therapeutics (NASDAQ:SGMO – Get Rating) from a sell rating to a hold rating in a report released on Friday. A number of other brokerages have also recently weighed in on SGMO. HC Wainwright dropped their price target on Sangamo Therapeutics from $15.00 to $5.00 in a research report on Monday, […]